VanEckUCITS · IrelandAccumulating

VanEck Bionic Engineering UCITS ETF (CYBO)

Price (USD): $18.60; —30 Sept 2026
Fund size: —; As reported by the issuer
Expense ratio: —; Per year
Distribution: Accumulating; USD share class

1Y return: -6.3%; In USD
3Y CAGR: 0.5%; Annualised, in USD
5Y CAGR: —; Annualised, in USD

Loading NAV history…

VanEck Bionic Engineering UCITS ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	-3.6%	+2.9%	-0.2%	-11.5%	-6.3%	+0.5%	—	—	-2.1%
	—	—	—	—	—	—	—	—	—
Difference	—	—	—	—	—	—	—	—	—

ETF details

Issuer: VanEck
Type: Not classified by its issuer
Ticker: CYBO
Other tickers: CYBG, CIB0
ISIN: IE0005TF96I9
WKN: A3DT2R
Domicile: Ireland
Share class currency: USD
Currency hedging: Unhedged
Distribution: Accumulating
Price history since: 9 Dec 2022 (3.8 years)
Expense ratio: —
Fund size: —

Prices and returns in US dollars as of 30 Sept 2026, from the fund's Xetra listing (CIB0) at each day's exchange rate; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other UCITS ETFs

Other UCITS ETFs not classified by their issuer.

VanEck Bionic Engineering UCITS ETF (CYBO)

Calendar-year returns

Risk statistics

ETF details

Other UCITS ETFs

Search